Justin Rectenwald

Justin Rectenwald is a skilled professional in the field of analytical development, currently serving as Senior Manager of CMC Analytical Development at Taysha Gene Therapies since November 2023. Rectenwald previously held positions at Atsena Therapeutics as a Scientist II in Assay Development and at Taysha Gene Therapies as a Scientist I, where responsibilities included ensuring product safety and quality through analytical method development. Prior experience includes time as a Scientist I at KBI Biopharma, which involved method development and Biacore SPR activities, and as a PhD Candidate at the University of North Carolina at Chapel Hill, focusing on Biophysics. Rectenwald's foundational experience includes internships and undergraduate research roles at prominent institutions. Educated at the University of North Carolina at Chapel Hill and Pennsylvania State University, Rectenwald holds a Bachelor's degree in Chemistry.